Back to Search
SHANGXIN YANG, PHD, D(ABMM)
PHD, D(ABMM)
Microbiology Specialist/Technologist
NPI: 1912480906Individual
Specialties, Licenses & Credentials
Microbiology Specialist/TechnologistPrimary
Specialist/Technologist, Pathology — Microbiology
Code: 246QM0900X
MTA43523(CA)
Research & Publications (20)
Caution! Analyze transcripts from conditional knockout alleles.
PMID 19093225·Transgenic Res·2009
7-preclinical
Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.
PMID 18178963·J Biol Chem·2008
7-preclinical
Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
PMID 18769635·J Clin Invest·2008
7-preclinical
A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
PMID 18172312·Cancer Res·2008
7-preclinical
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.
PMID 16862216·J Clin Invest·2006
7-preclinical
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
PMID 16540672·Cancer Res·2006
7-preclinical
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
PMID 16618753·Cancer Res·2006
8-other
Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
PMID 15994952·Cancer Res·2005
8-other
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
PMID 16014412·Proc Natl Acad Sci U S A·2005
4-observational
N-myristoyltransferase 1 is essential in early mouse development.
PMID 15753093·J Biol Chem·2005
7-preclinical
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.
PMID 15102698·Clin Cancer Res·2004
7-preclinical
Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.
PMID 19504095·Cancer Chemother Pharmacol·2010
7-preclinical
The expression and clinical significance of TGF-beta1 and MMP2 in human renal clear cell carcinoma.
PMID 19223381·Int J Surg Pathol·2010
8-other
A rapid coarse residue-based computational method for x-ray solution scattering characterization of protein folds and multiple conformational states of large protein complexes.
PMID 19486669·Biophys J·2009
7-preclinical
Comparison between a moving bed membrane bioreactor and a conventional membrane bioreactor on membrane fouling.
PMID 19640704·Bioresour Technol·2009
4-observational
Fabrication of highly reflective and conductive double-surface-silvered layers embedded on polymeric films through all-wet process at room temperature.
PMID 19555074·J Phys Chem B·2009
8-other
hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
PMID 19493423·Chin Med J (Engl)·2009
8-other
Fabrication of superparamagnetic magnetite/poly(styrene-co-12-acryloxy-9-octadecenoic acid) nanocomposite microspheres with controllable structure.
PMID 19640548·J Colloid Interface Sci·2009
8-other
Computational methods to study kinetics of DNA replication.
PMID 19563129·Methods Mol Biol·2009
7-preclinical
Spectroscopy of coherently coupled whispering-gallery modes in size-matched bispheres assembled on a substrate.
PMID 19571998·Opt Lett·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11633 SAN VICENTE BLVD, 4TH FLOOR, REAR BUILDING
LOS ANGELES, CA 90049 - Phone
- (310) 794-3614
Quick Facts
- NPI
- 1912480906
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile